Postoperative adjuvant chemotherapy for non-small cell lung cancer

Tatsuro Okamoto, Yukito Ichinose

Research output: Contribution to journalReview article

Abstract

Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.

Original languageEnglish
Pages (from-to)765-769
Number of pages5
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume32
Issue number6
Publication statusPublished - Jan 1 2005

Fingerprint

Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Tegafur
Survival
Uracil
Platinum
Meta-Analysis
Japan
Adenocarcinoma
Drug Therapy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Postoperative adjuvant chemotherapy for non-small cell lung cancer. / Okamoto, Tatsuro; Ichinose, Yukito.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 32, No. 6, 01.01.2005, p. 765-769.

Research output: Contribution to journalReview article

Okamoto, Tatsuro ; Ichinose, Yukito. / Postoperative adjuvant chemotherapy for non-small cell lung cancer. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2005 ; Vol. 32, No. 6. pp. 765-769.
@article{5cd40385031b4c93ad7dbfddb8a25b8f,
title = "Postoperative adjuvant chemotherapy for non-small cell lung cancer",
abstract = "Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.",
author = "Tatsuro Okamoto and Yukito Ichinose",
year = "2005",
month = "1",
day = "1",
language = "English",
volume = "32",
pages = "765--769",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "6",

}

TY - JOUR

T1 - Postoperative adjuvant chemotherapy for non-small cell lung cancer

AU - Okamoto, Tatsuro

AU - Ichinose, Yukito

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.

AB - Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.

UR - http://www.scopus.com/inward/record.url?scp=21244456521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244456521&partnerID=8YFLogxK

M3 - Review article

C2 - 15984513

AN - SCOPUS:21244456521

VL - 32

SP - 765

EP - 769

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 6

ER -